KNIGHTSCOPE INC-A (KSCP) Fundamental Analysis & Valuation

NASDAQ:KSCP • US49907V2016

4.02 USD
+0.11 (+2.81%)
Last: Mar 10, 2026, 10:35 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This KSCP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Taking everything into account, KSCP scores 3 out of 10 in our fundamental rating. KSCP was compared to 82 industry peers in the Commercial Services & Supplies industry. KSCP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. KSCP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. KSCP Profitability Analysis

1.1 Basic Checks

  • In the past year KSCP has reported negative net income.
  • In the past year KSCP has reported a negative cash flow from operations.
  • In the past 5 years KSCP always reported negative net income.
  • In the past 5 years KSCP always reported negative operating cash flow.
KSCP Yearly Net Income VS EBIT VS OCF VS FCFKSCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • KSCP has a Return On Assets of -72.41%. This is amonst the worse of the industry: KSCP underperforms 86.59% of its industry peers.
  • The Return On Equity of KSCP (-110.54%) is worse than 78.05% of its industry peers.
Industry RankSector Rank
ROA -72.41%
ROE -110.54%
ROIC N/A
ROA(3y)-108.33%
ROA(5y)-145.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KSCP Yearly ROA, ROE, ROICKSCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

  • KSCP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KSCP Yearly Profit, Operating, Gross MarginsKSCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. KSCP Health Analysis

2.1 Basic Checks

  • KSCP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • KSCP has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, KSCP has less shares outstanding
  • The debt/assets ratio for KSCP is higher compared to a year ago.
KSCP Yearly Shares OutstandingKSCP Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
KSCP Yearly Total Debt VS Total AssetsKSCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • Based on the Altman-Z score of -6.99, we must say that KSCP is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -6.99, KSCP is doing worse than 85.37% of the companies in the same industry.
  • A Debt/Equity ratio of 0.16 indicates that KSCP is not too dependend on debt financing.
  • KSCP has a Debt to Equity ratio of 0.16. This is in the better half of the industry: KSCP outperforms 68.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z -6.99
ROIC/WACCN/A
WACC8.46%
KSCP Yearly LT Debt VS Equity VS FCFKSCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

  • KSCP has a Current Ratio of 3.62. This indicates that KSCP is financially healthy and has no problem in meeting its short term obligations.
  • KSCP has a Current ratio of 3.62. This is amongst the best in the industry. KSCP outperforms 86.59% of its industry peers.
  • A Quick Ratio of 3.37 indicates that KSCP has no problem at all paying its short term obligations.
  • The Quick ratio of KSCP (3.37) is better than 89.02% of its industry peers.
Industry RankSector Rank
Current Ratio 3.62
Quick Ratio 3.37
KSCP Yearly Current Assets VS Current LiabilitesKSCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. KSCP Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 70.99% over the past year.
  • The Revenue has been growing slightly by 5.50% in the past year.
  • KSCP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.95% yearly.
EPS 1Y (TTM)70.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.63%
Revenue 1Y (TTM)5.5%
Revenue growth 3Y46.88%
Revenue growth 5Y28.95%
Sales Q2Q%23.51%

3.2 Future

  • Based on estimates for the next years, KSCP will show a very strong growth in Earnings Per Share. The EPS will grow by 32.23% on average per year.
  • KSCP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.26% yearly.
EPS Next Y64.4%
EPS Next 2Y32.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.37%
Revenue Next 2Y20.26%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
KSCP Yearly Revenue VS EstimatesKSCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
KSCP Yearly EPS VS EstimatesKSCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

1

4. KSCP Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for KSCP. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KSCP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KSCP Price Earnings VS Forward Price EarningsKSCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KSCP Per share dataKSCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as KSCP's earnings are expected to grow with 32.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.23%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. KSCP Dividend Analysis

5.1 Amount

  • No dividends for KSCP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KSCP Fundamentals: All Metrics, Ratios and Statistics

KNIGHTSCOPE INC-A

NASDAQ:KSCP (3/10/2026, 10:35:20 AM)

4.02

+0.11 (+2.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-12
Earnings (Next)04-01
Inst Owners11.19%
Inst Owner Change37.12%
Ins Owners0.02%
Ins Owner Change0%
Market Cap46.27M
Revenue(TTM)11.61M
Net Income(TTM)-29.73M
Analysts82.22
Price Target15.3 (280.6%)
Short Float %14.55%
Short Ratio3.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.31%
Min EPS beat(2)-17.65%
Max EPS beat(2)26.27%
EPS beat(4)3
Avg EPS beat(4)19.85%
Min EPS beat(4)-17.65%
Max EPS beat(4)60.65%
EPS beat(8)4
Avg EPS beat(8)-0.51%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.59%
Min Revenue beat(2)-5.6%
Max Revenue beat(2)16.78%
Revenue beat(4)3
Avg Revenue beat(4)8.84%
Min Revenue beat(4)-5.6%
Max Revenue beat(4)16.78%
Revenue beat(8)5
Avg Revenue beat(8)6.66%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.75%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.99
P/FCF N/A
P/OCF N/A
P/B 1.72
P/tB 1.93
EV/EBITDA N/A
EPS(TTM)-3.94
EYN/A
EPS(NY)-2.73
Fwd EYN/A
FCF(TTM)-2.23
FCFYN/A
OCF(TTM)-2.19
OCFYN/A
SpS1.01
BVpS2.34
TBVpS2.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -72.41%
ROE -110.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-108.33%
ROA(5y)-145.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.7%
Cap/Sales 3.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.62
Quick Ratio 3.37
Altman-Z -6.99
F-Score5
WACC8.46%
ROIC/WACCN/A
Cap/Depr(3y)9.14%
Cap/Depr(5y)7.03%
Cap/Sales(3y)1.97%
Cap/Sales(5y)1.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.63%
EPS Next Y64.4%
EPS Next 2Y32.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.5%
Revenue growth 3Y46.88%
Revenue growth 5Y28.95%
Sales Q2Q%23.51%
Revenue Next Year10.37%
Revenue Next 2Y20.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.71%
OCF growth 3YN/A
OCF growth 5YN/A

KNIGHTSCOPE INC-A / KSCP FAQ

Can you provide the ChartMill fundamental rating for KNIGHTSCOPE INC-A?

ChartMill assigns a fundamental rating of 3 / 10 to KSCP.


What is the valuation status for KSCP stock?

ChartMill assigns a valuation rating of 1 / 10 to KNIGHTSCOPE INC-A (KSCP). This can be considered as Overvalued.


Can you provide the profitability details for KNIGHTSCOPE INC-A?

KNIGHTSCOPE INC-A (KSCP) has a profitability rating of 0 / 10.


How financially healthy is KNIGHTSCOPE INC-A?

The financial health rating of KNIGHTSCOPE INC-A (KSCP) is 5 / 10.